期刊文献+

2010年风湿免疫病学主要临床进展 被引量:2

下载PDF
导出
摘要 免疫学是21世纪发展最为迅速的学科之一,以免疫学为基础的临床风湿病学的发展更是日新月异,仅在过去的2010年1年中,诊断和治疗方面研究进展令人惊叹,特别是欧洲风湿病联盟(EuropeanI.eagueAgainstRheumatism,EULAR)为风湿病诊治所做的贡献更令人鼓舞。生物制剂应用于临床也为我们开启了风湿病治疗的新纪元。
出处 《临床荟萃》 CAS 2011年第7期553-556,共4页 Clinical Focus
  • 相关文献

参考文献17

  • 1Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/ European League Against Rheumatism collaborative initiative [J]. Ann Rheum Dis,2010,69(9): 1580 1588.
  • 2Smolen JS, Landewé R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs[J]. Ann Rheum Dis,2010,69(6):964-975.
  • 3Smolen JS, Aletaha D, Bijlsma JW, et al. Treating rheumatoid arthritis to target: recommendations of an international task foree[J]. Ann Rheum Dis,2010,69(4):631-637.
  • 4Peters MJ, Symmons DP, McCarey D,et al. EULAR evidencebased reeommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms ot inflammatory arthritis[J] . Ann Rheum Dis, 2010,69 (2) : 325-331.
  • 5Wiens A,Venson R,Correr CJ,et at. Meta-analysis of the efficacy and safety of adalimumab, etanercept, and infliximab for the treatment of rheumatoid arthritis[J]. Pharmacotherapy, 2010, 30 (4) :339-353.
  • 6Emery P, Breedveld F, van der Heijde D, et al. Two-year clinical and radiographic results with combination etanerceptmethotrexate therapy versus monotherapy in early rheumatoid arthritis: a two-year, double-blind, randomized study [ J ]. Arthritis Rheum,2OlO,6Z(a) :674-682.
  • 7Nishimoto N, lto K, Takagi N. Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis:meta-analysis of six initial trials and five long-term extensions[J]. Mod Rheumatol,2010,20 (3) :222-232.
  • 8An MM,Zou Z,Shen H,et al. The addition of toeilizumab to DMARD therapy for rheumatoid arthritis: a meta-analysis of randomized controlled trials[J]. Eur J Clin Pharmacol, 2010, 66(1) :49-59.
  • 9Woodrick R, Ruderman EM. Anti-interleukin-6 therapy in rheumatoid arthritis[J] . Bull NYU Hosp Jt Dis,2010,68(3) 211-217.
  • 10Mosca M,Tani C, Aringer M, et al. European I.eague Against Rheumatism recommendations for monitoring patients with systemic lupus erythernatosus in clinical practice and in observational studies[J] . Ann Rheum Dis, 2010,69 (7) : 1269- 1274.

同被引文献20

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部